Wintest
6721
D. Western Therapeutics Institute
4576
Ridge-i
5572
Hamee
3134
River Eletec
6666
(Q2)Mar 31, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | |
---|---|---|---|
Assets | |||
Current assets | |||
Cash, cash equivalents and short term investments | --732.38M | -35.04%781.58M | --1.2B |
-Cash and cash equivalents | --732.38M | -35.04%781.58M | --1.2B |
Receivables | --595.98M | 54.49%547.06M | --354.1M |
-Accounts receivable | --595.98M | 54.49%547.06M | --354.1M |
Prepaid assets | ---- | 16.89%51.52M | --44.07M |
Other current assets | --83.6M | -1,109.95%-12.48M | --1.24M |
Total current assets | --1.41B | -14.65%1.37B | --1.6B |
Non current assets | |||
Net PPE | --47.77M | --46.58M | --0 |
-Gross PP&E | ---- | 267.60%69.54M | --18.92M |
-Accumulated depreciation | ---- | -21.36%-22.96M | ---18.92M |
Prepaid assets-non current | ---- | 8.13%69.37M | --64.15M |
Total investment | --112.71M | --995K | --0 |
-Other investment | ---- | --995K | ---- |
Other non current assets | --1K | ---- | ---- |
Total non current assets | --160.48M | 82.29%116.94M | --64.15M |
Total assets | --1.57B | -10.92%1.48B | --1.67B |
Liabilities | |||
Current liabilities | |||
Financial liabilities | --77.78M | -6.31%103.86M | --110.86M |
-Current debt and capital lease obligation | --77.78M | -6.31%103.86M | --110.86M |
-Including:Current debt | --77.78M | -6.31%103.86M | --110.86M |
Payables | --855.16M | 67.74%829.55M | --494.54M |
-accounts payable | --504.1M | 50.61%471.18M | --312.85M |
-Total tax payable | --1.15M | 2,383.47%69.71M | --2.81M |
-Other payable | --349.91M | 61.37%288.67M | --178.88M |
Accrued and deferred income | ---- | 112.80%136.33M | --64.06M |
Other current liabilities | --233.11M | 772.33%18.6M | --2.13M |
Current liabilities | --1.17B | 62.05%1.09B | --671.59M |
Non current liabilities | |||
Non current financial liabilities | --369.95M | 16.41%83.17M | --71.44M |
-Long term debt and capital lease obligation | --369.95M | 16.41%83.17M | --71.44M |
-Including:Long term debt | --369.95M | 16.41%83.17M | --71.44M |
Other non current liabilities | --2K | ---- | --1K |
Total non current liabilities | --369.96M | 16.41%83.17M | --71.44M |
Total liabilities | --1.54B | 57.67%1.17B | --743.03M |
Shareholders'equity | |||
Share capital | --179M | 0.00%99M | --99M |
-common stock | --179M | 0.00%99M | --99M |
Additional paid-in capital | --2.36B | 3.05%2.28B | --2.21B |
Retained earnings | ---2.5B | -48.89%-2.07B | ---1.39B |
Other equity interest | --1.3M | 419.20%1.3M | --250K |
Total stockholders'equity | --36.44M | -66.10%313.11M | --923.62M |
Total equity | --36.44M | -66.10%313.11M | --923.62M |
Currency Unit | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |